4,5-Dihydroxytryptamine

4,5-Dihydroxytryptamine Full Name

4,5-dihydroxytryptamine (conjugated)

4,5-Dihydroxytryptamine Introduction

4,5-Dihydroxytryptamine, commonly abbreviated as 4,5-DHT, is a naturally occurring indoleamine derivative and a hydroxylated analog of serotonin (5-hydroxytryptamine, 5-HT)—the primary monoamine neurotransmitter regulating mood, cognition, and peripheral physiological function. Classified as a selective serotonergic neurotoxin in experimental pharmacology, 4,5-DHT is distinguished by the addition of a hydroxyl group at the 4-position of the indole ring (in addition to the 5-position hydroxyl group of serotonin), a structural modification that confers its unique biological properties: weak intrinsic neurotransmitter activity but high selectivity for damaging serotoninergic (5-HTergic) nerve terminals. Though endogenously present in trace amounts in mammalian tissues, 4,5-DHT is best characterized as a critical research tool in neuroscience, used to selectively ablate central and peripheral 5-HTergic pathways to elucidate the physiological and pathophysiological roles of the serotonin system.

Figure 1. Strcuture of 4,5-Dihydroxytryptamine.

Pathophysiological Potential
While 4,5-DHT has no normal physiological role, it may contribute to serotoninergic neuron damage under pathological conditions that increase its production or impair its metabolism. Potential pathophysiological scenarios include:
Oxidative stress: Elevated reactive oxygen species (e.g., in neurodegenerative disease, stroke, or traumatic brain injury) may accelerate the hydroxylation of serotonin to 4,5-DHT and inhibit its metabolism, leading to local accumulation and mild 5-HTergic terminal damage.
Increased serotonin turnover: Conditions such as major depressive disorder, anxiety, or chronic stress are associated with elevated serotonin synthesis and turnover, which may increase CYP-mediated 4,5-DHT production. This could exacerbate 5-HTergic neuron dysfunction in these disorders, creating a vicious cycle of increased serotonin metabolism, 4,5-DHT accumulation, and further terminal damage.
Enzyme dysfunction: Genetic polymorphisms or inhibition of MAO/COMT (e.g., by certain drugs or toxins) may slow 4,5-DHT metabolism, leading to its buildup in 5-HTergic tissues.

Conclusion
4,5-Dihydroxytryptamine (4,5-DHT) is a unique indoleamine derivative that, despite its trace endogenous presence, has become a cornerstone research tool in neuroscience and pharmacology due to its high selectivity for ablating serotoninergic (5-HTergic) nerve terminals. Its defining property—SERT-mediated uptake into 5-HTergic neurons followed by oxidative toxicity—allows for the precise, selective ablation of central and peripheral 5-HTergic pathways without off-target effects on other monoamine systems, making it the gold standard for studying the physiological and pathophysiological roles of serotonin.

Alternate Names for 4,5-Dihydroxytryptamine

4,5-DHT; 4,5-dihydroxytryptamine;